TMRW Life Sciences Revenue and Competitors

Location

$153.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • TMRW Life Sciences's estimated annual revenue is currently $18.9M per year.(i)
  • TMRW Life Sciences's estimated revenue per employee is $155,000
  • TMRW Life Sciences's total funding is $153.5M.

Employee Data

  • TMRW Life Sciences has 122 Employees.(i)
  • TMRW Life Sciences grew their employee count by -16% last year.

TMRW Life Sciences's People

NameTitleEmail/Phone
1
Founder & Co-ChairmanReveal Email/Phone
2
CIOReveal Email/Phone
3
COO & CFOReveal Email/Phone
4
VP Global Service and SupportReveal Email/Phone
5
VP Clinical StrategyReveal Email/Phone
6
SVP, Global Procurement & Supply ChainReveal Email/Phone
7
Director, AccountingReveal Email/Phone
8
Managing Director Software EngineeringReveal Email/Phone
9
Design Assurance Quality Engineering DirectorReveal Email/Phone
10
Chief Legal Officer and General CounselReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$38.2M254-19%$178M$1.4B
Add Company

What Is TMRW Life Sciences?

TMRW safeguards the worldᅢᄁ¬ツᆲ¬トᄁs most precious cells for life. The TMRW platform revolutionizes the management, identification, and storage of fertility cells, replacing the manual and analog methods that have remained largely unchanged since IVF was first used in animal husbandry more than 50 years ago. Developed in partnership with leading fertility doctors and embryologists, TMRWᅢᄁ¬ツᆲ¬トᄁs technology will play a central role in the births of tens of millions of people in the coming years by reducing the risk of loss or misidentification of the priceless cells used in IVF. Our automation eliminates error-prone manual tasks in the embryology lab, allowing embryologists to focus on the most skilled and technical aspects of their work. The TMRW team includes many of the worldᅢᄁ¬ツᆲ¬トᄁs most celebrated pioneers in clinical medicine, reproductive biology, embryology, and cryogenic biobanking who have synthesized their collective knowledge, vision, and experience in the development of the TMRW platform. Weᅢᄁ¬ツᆲ¬トᄁve brought together a diverse, cross-disciplinary team to achieve our mission ᅢᄁ¬ツᆲ¬タン and weᅢᄁ¬ツᆲ¬トᄁre always looking for more innovators to join us in creating a better tomorrow.

keywords:N/A

$153.5M

Total Funding

122

Number of Employees

$18.9M

Revenue (est)

-16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TMRW Life Sciences News

2022-04-17 - TMRW LIFE SCIENCES NAMED FAST COMPANY'S #1 MOST ...

TMRW LIFE SCIENCES NAMED FAST COMPANY'S #1 MOST INNOVATIVE BIOTECH COMPANY FOR GROUND-BREAKING IVF TECHNOLOGY. TMRW Life Sciences, Inc. (...

2022-03-30 - IVF tech firm TMRW Life Sciences hires PR agency for UK launch

The PHA Group will lead TMRW Life Sciences' UK PR launch through a 12-month campaign for the client, which owns what is billed as the...

2022-03-30 - TMRW Life Sciences Appoints Sandra Santilli as Chief People Officer

NEW YORK, April 5, 2022 /PRNewswire/ -- TMRW Life Sciences, Inc. ("TMRW" or "the Company"), creator of the world's first and only automated,...

2021-07-20 - TMRW Life Sciences Raises $105 Million to Accelerate Global Rollout of World's First Automated Platform for IVF Egg & Embryo Management

NEW YORK, July 20, 2021 /PRNewswire/ -- TMRW Life Sciences, Inc., the life sciences technology firm providing the world's first automated platform for tracking, monitoring, and storage of frozen eggs and embryos used in in vitro fertilization (IVF), announced the completion of a $105 million S ...

2021-07-20 - TMRW Life Sciences Raises $105M in Funding

TMRW Life Sciences, Inc., a NYC-based life sciences technology company providing an automated platform for tracking, monitoring, and storage of frozen eggs and embryos used in in vitro fertilization (IVF), completed a $105m Series C equity and debt financing. The equity round was led by Transfo ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.9M122-7%$100.4M
#2
$30.5M12210%N/A
#3
$18.3M12211%N/A
#4
$29.9M12216%$162.1M
#5
$32.3M12220%N/A